• 034535031
Final Price €13.50
check_circle Available (24 Items)
  Convenient and safe payments

Even with a credit card

  Shipping in 48h-72h all over the world

FREE in Italy over € 39.90

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service

Home Others products at unbeatable price


Discover all products


Therapeutic indications

BRIOVITASE is indicated in all states of potassium and magnesium deficiency, which generally manifest themselves with a feeling of tiredness, muscle weakness and cramps. These deficiencies can be caused by excessive sweating, intense physical activity, profuse diarrhea and vomiting.

Dosage and method of use

The adult dose is 2 sachets of powder for oral suspension per day. It takes about 4 days of therapy before a subjective clinical improvement can be noticed. It is recommended to continue the administration of BRIOVITASE for at least two weeks.


Hypersensitivity to the active substances or to any of the excipients. The administration of high doses of potassium aspartate and magnesium is contraindicated in the presence of severe renal or adrenal insufficiency. States of acute dehydration. Congenital myotonia.

Side effects

Abdominal discomfort, nausea, vomiting and diarrhea have been reported occasionally. These symptoms can disappear by administering the product in the right dose after meals.

Special warnings

Caution is needed in the treatment of cardiopathic patients with renal insufficiency. The product contains sucrose and when taken according to the recommended dosage each dose provides 3.4 g of sucrose. It is not suitable in cases of hereditary fructose intolerance, glucose and galactose malabsorption syndrome and sucrase and isomaltase deficiency. The product contains a source of phenylalanine.

Pregnancy and breastfeeding

There are no particular limitations.

Expiry and retention

None in particular except those common to all drugs.

Interactions with other drugs

There are no known drug interactions following concomitant administration of other drugs.


The ingestion of quantities of BRIOVITASE, even much higher than those recommended, should not induce serious disturbances; diarrhea, nausea, vomiting, sometimes gastrointestinal bleeding may be noted. In the event of an overdose, it will still be necessary to induce vomiting, so consult a doctor to evaluate the opportunity to perform a gastric lavage.

Active principles

One sachet contains: Magnesium aspartate tetrahydrate mg 450 Potassium aspartate hemihydrate mg 450


One sachet contains: Citric acid; pectin; orange flavor; mandarin aroma; grapefruit flavoring; aspartame; sodium cyclamate; sucrose.

24 Items